HansBiomed Corporation Free Cash Flow Generation Index
HansBiomed Corporation free cash flow generation index. HansBiomed Corporation (042520) has a Free Cash Flow Generation Index of 0.63x as of September 2025. Free cash flow of ₩756.94 Million represents 1% of operating cash flow (₩1.21 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of HansBiomed Corporation (2012–2025)
Free cash flow generation index of HansBiomed Corporation from 2012 to 2025. Historical FCF Generation Index trend for HansBiomed Corporation across 10 annual periods. See HansBiomed Corporation leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
HansBiomed Corporation Free Cash Flow Generation Index by Year (2012–2025)
HansBiomed Corporation free cash flow generation index by year from 2012 to 2025. Year-by-year Free Cash Flow Generation Index for HansBiomed Corporation. For the full cash flow conversion analysis, see cash flow conversion of HansBiomed Corporation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.52x | ₩-1.44 Billion | ₩318.34 Million | ₩1.76 Billion | ▼ -642.7% |
| 2024 | -0.61x | ₩-1.07 Billion | ₩1.76 Billion | ₩2.83 Billion | ▼ -2.8% |
| 2020 | -0.59x | ₩-3.41 Billion | ₩5.75 Billion | ₩7.05 Billion | ▼ -119.6% |
| 2019 | 3.02x | ₩23.28 Billion | ₩7.71 Billion | ₩15.56 Billion | ▲ +111.0% |
| 2018 | 1.43x | ₩7.44 Billion | ₩5.20 Billion | ₩2.24 Billion | ▼ -57.1% |
| 2017 | 3.33x | ₩18.64 Billion | ₩5.60 Billion | ₩13.05 Billion | ▲ +21.1% |
| 2015 | 2.75x | ₩9.54 Billion | ₩3.47 Billion | ₩6.07 Billion | ▼ -60.7% |
| 2014 | 7.01x | ₩14.45 Billion | ₩2.06 Billion | ₩12.39 Billion | ▲ +69.9% |
| 2013 | 4.13x | ₩9.62 Billion | ₩2.33 Billion | ₩7.29 Billion | ▲ +253.0% |
| 2012 | 1.17x | ₩1.75 Billion | ₩1.50 Billion | ₩253.56 Million | — |